Fusion Study Logo
  • Find a Study Site
  • The Study
  • About FUS-ALS
  • FAQs
Am I Eligible?

Would you like to know more about the FUSION study? Contact Us

Home » About FUS-ALS

Amyotrophic Lateral Sclerosis (ALS) is a rare neurological disorder that affects motor neurons and causes trouble with muscle movements like speaking, walking, or gripping.

ALS affects an estimated two to five per 100,000 people worldwide.

Only a small percentage of cases have a known genetic cause.

Between 1 % to 5% of ALS cases are caused by a mutation in the FUS gene.

This type of ALS often progresses more rapidly and symptoms appear at a younger age.

When Amyotrophic Lateral Sclerosis (ALS) symptoms emerge during adolescence, mutations in the FUS gene are likely to blame, findings from a case report suggest.

Mutations in this gene also are the cause of some adult-onset ALS cases.

However, FUS-associated ALS is more aggressive in children in whom these mutations more profoundly affect the biological mechanisms of the FUS protein, research indicates.

While ALS affects mostly adults at advanced ages, the disease also can manifest before the age of 25 (juvenile ALS), or even before adulthood (pediatric ALS).

In adults, only about 10% of cases are caused by genetic mutations,

but the number of ALS cases caused by known genetic mutations appears to increase significantly in early-on­set disease.

FUS is the most commonly mutated gene in juvenile and pediatric ALS, but it causes only about 5% of cases in adults.

It is unclear why younger patients with FUS mutations exhibit a more aggressive disease course than adults. In adults, only about 10% of cases are caused by genetic mutations, but the number of ALS cases caused by known genetic mutations appears to increase significantly in early-onset disease.

ALS is also called:

Lou Gehrig’s disease and motor neuron disease.

questions

Interested in participating in the FUSION study?

Take our questionnaire to find out if you may be eligible.

Get Started
Ionis logo

©2023 Ionis Pharmaceuticals® is a registered trademark of Ionis Pharmaceuticals, Inc.

ionistrials.com
Privacy Policy | Contact
MENU
  • Find a Study Site
  • The Study
  • About FUS-ALS
  • FAQs
  • Get Started

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Fusion Study
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.